A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria

Biological Psychiatry

Volumn 45, Issue 3, 1999, Pages 313-320

  Steinberg, Susanne ^a   Annable, Lawrence ^b   Young, Simon N ^b   Liyanage, Nilani ^b  

^a ST MARY S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Depression; Irritability; L tryptophan; Premenstrual dysphoria; Serotonin

Indexed keywords

PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; EOSINOPHILIA MYALGIA SYNDROME; FEMALE; HUMAN; IRRITABILITY; LUTEAL PHASE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN METABOLISM; VERTIGO;

ADULT; AFFECTIVE SYMPTOMS; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; DIZZINESS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE MOOD; PLACEBOS; PREMENSTRUAL SYNDROME; QUALITY OF LIFE; SEROTONIN AGENTS; TREATMENT OUTCOME; TRYPTOPHAN;

EID: 0033082530     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00005-5     Document Type: Article

References (50)

1. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed rev. 1987;American Psychiatric Press, Washington, DC.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
3. Bancroft J., Cook A., Davidson D., Bennie J., Goodwin G.M. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med. 21:1991;305-312.
4. Beitman B.D., Dunner D.L. L-Tryptophan in the maintenance treatment of bipolar II manic-depressive illness. Am J Psychiatry. 139:1982;1498-1499.
5. Belongia E.A., Mayeno A.N., Osterholm M.T. The eosinophilia-myalgia syndrome and tryptophan. Annu Rev Nutr. 12:1992;235-256.
6. Benkelfat C., Ellenbogen M.A., Dean P., Palmour R.M., Young S.N. Mood-lowering effect of tryptophan depletion Enhanced susceptibility in young men at genetic risk for major affective disorders . Arch Gen Psychiatry. 51:1994;687-697.
7. Brzezinski A.A., Wurtman J.J., Wurtman R.J., Gleason R., Greenfield J., Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves mood of women with premenstrual depression. Obstet Gynecol. 76:1990;296-301.
8. Casper R.F., Powell A.M. Premenstrual syndrome Documentation by a linear analog scale compared with two descriptive scales . Am J Obstet Gynecol. 155:1986;862-867.
9. Chouinard G., Jones B.D., Young S.N., Annable L. Potentiation of lithium by tryptophan in a patient with bipolar illness. Am J Psychiatry. 136:1979;719-720.
10. Ellenbogen M.A., Young S.N., Dean P., Palmour R.M., Benkelfat C. Mood response to acute tryptophan depletion in healthy volunteers Sex differences and temporal stability . Neuropsychopharmacology. 15:1996;465-474.
11. Eriksson E., Alling C., Andersch B., Andersson K., Berggren U. Cerebrospinal fluid levels of monoamine metabolites A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome . Neuropsychopharmacology. 11:1994;201-213.
12. Eriksson E., Hedberg M.A., Andersch B., Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 12:1995;167-176.
13. Freeman E.W., Rickels K., Sondheimer S.J. Fluvoxamine for premenstrual dysphoric disorder A pilot study . J Clin Psychiatry. 57:1996;56-60.
14. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;U.S. Department of Health, Education and Welfare, Rockville, MD.
15. Hand D.J., Taylor C.C. Multivariate Analysis of Variance and Repeated Measures. 1987;Chapman & Hall, London.
16. Harrison W.M., Endicott J., Nee J. Treatment of premenstrual depression with nortriptyline A pilot study . J Clin Psychiatry. 50:1989;136-139.
17. Hendrix L.J., Carter M.W., Scott D.T. Covariance analyses with heterogeneity of slopes in fixed models. Biometrics. 38:1982;641-650.
18. Hertz D., Sulman F.G. Preventing depression with tryptophan. Lancet. i:1968;531-532.
19. Kimberly A., Yonkers M.D., Halbreich U., Freeman E., Brown C., Endicott J., Frank E., Parry B., Pearlstein T., Severino S., Stout A., Stone A., Harrison W. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA. 278:1997;983-988.
20. Landry P., Chouinard G., Primeau F. Lithium-tryptophan combination in the maintenance treatment of bipolar affective illness. Lithium. 2:1991;135-140.
21. Lewinsohn P.M., Mermelstein R.M., Alexander C., MacPhillamy D.J. The Unpleasant Events Schedule A scale for the measurement of adversive events . J Clin Psychol. 41:1985;483-498.
22. MacPhillamy D.J., Lewinsohn P.M. The Pleasant Events Schedule Studies on reliability, validity, and scale intercorrelation . J Consult Clin Psychol. 50:1982;363-380.
23. McCormack H.M., Horne D.J., Sheather S. Clinical applications of visual analogue scales A critical review . Psychol Med. 18:1988;1007-1019.
24. Menkes D.B., Taghavi E., Mason P.A., Howard R.C. Fluoxetine's spectrum of action in premenstrual syndrome. Int Clin Psychopharmacol. 8:1993;95-102.
25. Menkes D.B., Coates D.C., Fawcett J.P. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 32:1994;37-44.
26. Morand C., Young S.N., Ervin F.R. Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry. 18:1983;575-578.
27. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA. 94:1997;5308-5313.
28. Raleigh M.J., Brammer G.L., Yuwiler A., Flannery J.W., McGuire M.T., Geller E. Serotonergic influences on the social behavior of vervet monkeys (Cercopithecus aethiops sabaeus). Exp Neurol. 68:1980;322-334.
29. Rapkin A.J., Reading A.E., Woo S., Goldman L.M. Tryptophan and neutral amino acids in premenstrual syndrome. Am J Obstet Gynecol. 165:1991;1830-1833.
30. Reid R.L. Premenstrual syndrome. Curr Probl Obstet Fertil. 8:1985;1-57.
31. Rickels K., Freeman E., Sondheimer S. Buspirone in treatment of premenstrual syndrome. Lancet. i:1989;777.
32. Rubinow D.R., Roy-Byrne P., Hoban M.C., Gold P.W., Post R.M. Prospective assessment of menstrually related mood disorders. Am J Psychiatry. 141:1984;684-686.
33. Schmidt D.J., Grover G.N., Hoban C., Rubinow D.R. State-dependent alterations in the perception of life events in menstrual-related disorders. Am J Psychiatry. 147:1990;230-234.
34. Spanier G.B. Measuring dyadic adjustment New scales for assessing the quality of marriage and similar dyads . J Marr Fam. 38:1976;15-28.
35. Spanier G.B., Thompson L. A confirmatory analysis of the dyadic adjustment scale. J Marr Fam. 44:1982;731-738.
36. Steinberg S., Annable L., Young S.N., Bélanger M.C. Tryptophan in the treatment of late luteal phase dysphoric disorder A pilot study . J Psychiatry Neurosci. 19:1994;114-119.
37. Steiner M., Haskett R.F., Carrol B.J. Premenstrual tension syndrome The development of research diagnostic criteria and new rating scales . Acta Psychiatr Scand. 65:1980;229-240.
38. Steiner M., Steinberg S., Stewart D., Carter D., Berger C., Reid R., et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 332:1995;1529-1534.
39. Steiner M, Streiner DL, Steinberg S, Stewart D, Carter D, Berger C, et al (in press): The measurement of premenstrual dysphoria. J Affect Disord.
40. Stone A.B., Pearlstein T.B., Brown W.A. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry. 52:1991;290-293.
41. Sundblad C., Hedberg M.A., Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome A placebo-controlled trial . Neuropsychopharmacology. 9:1993;133-145.
42. Thomson J., Rankin H., Ashcroft G.W., Yates C.M., McQueen J.K., Cummings S.W. The treatment of depression in general practice A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo . Psychol Med. 12:1982;741-751.
43. Veeninga A.T., Westenberg H.G.M. Serotonergic function and late luteal phase dysphoric disorder. Psychopharmacology (Berl). 108:1992;153-158.
44. Veeninga A.T., Westenberg H.G.M., Weusten J.T.N. Fluvoxamine in the treatment of menstrually related mood disorders. Psychopharmacology (Berl). 102:1990;414-416.
45. Volavka J., Crowner M., Brizer D., Convit A., van Praag H.M., Suckow R.F. Tryptophan treatment of aggressive psychiatric inpatients. Biol Psychiatry. 28:1990;728-732.
46. Wilkins K. Eosinophilia-myalgia syndrome. Can Med Assoc J. 142:1990;1265-1266.
47. Wood S.H., Mortola J.F., Chan Y.F., Moossazadeh F., Yen S.S.C. Treatment of premenstrual syndrome with fluoxetine A double-blind, placebo-controlled, crossover study . Obstet Gynecol. 80:1992;339-344.
48. Yonkers K.A., Gullion C., Williams A., Novak K., Rush A.J. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol. 16:1996;3-8.
49. Young S.N. The clinical psychopharmacology of tryptophan. Wurtman R.J., Wurtman J.J. Nutrition and the Brain, Volume 7, Food Constituents Affecting Normal and Abnormal Behaviors. 1986;49-88 Raven Press, New York.
50. Zuckerman M., Lubin B. Manual for the Multiple Affect Adjective Checklist. 1965;Educational and Industrial Testing Service, San Diego, CA.